Austar Lifesciences Ltd. is an investment holding company, which engages in the provision of engineering solutions to pharmaceutical manufacturers and research institutes. The company is headquartered in Shanghai, Shanghai and currently employs 1,446 full-time employees. The company went IPO on 2014-11-07. The firm operates three segments. The Integrated Process and Packaging Equipment & Systems segment mainly includes liquid process systems and powder-solid systems. The Consulting, Digitalization and Construction segment mainly includes design consulting, compliance service systems, as well as cleanroom and automation control systems. The Life Science Equipment and Consumables segment focuses on life science and technology consumables, advanced treatment and advanced bioprocess technologies.
Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
1,461
1,500
1,763
2,156
2,015
1,295
Hasılat Artışı (YoY)
-3%
-15%
-18%
7%
56%
23%
Satınalma Maliyeti
1,166
1,199
1,427
1,668
1,536
972
Brüt Kâr
294
301
336
488
479
323
Satış, Genel ve İdari
238
233
327
299
300
255
Araştırma ve Geliştirme
46
53
55
70
65
48
İşletme Giderleri
256
262
377
366
361
296
Diğer Finansman Gelirleri (Giderleri)
--
--
--
--
--
--
Kâr Öncesi Gelir
42
21
-34
119
319
41
Kira Vergisi Gideri
9
7
0
18
46
9
Net Kâr
35
16
-113
87
277
33
Net Income Growth
Kâr Artışı
-152%
-113.99%
-229.99%
-69%
739%
313%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
512.58
512.58
512.58
512.58
512.58
512.58
Hisse Değişimi (Yıllık Üst Üste)
0%
0%
0%
0%
0%
0%
EPS (Diluted)
0.06
0.03
-0.22
0.17
0.54
0.06
EPS Artışı
-153%
-113.99%
-229%
-69%
737%
309%
Öz sermaye akışı
--
78
-131
-155
-204
25
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
20.12%
20.06%
19.05%
22.63%
23.77%
24.94%
Faaliyet Kâr Marjı
2.53%
2.53%
-2.32%
5.65%
5.8%
2%
Kâr Marjı
2.39%
1.06%
-6.4%
4.03%
13.74%
2.54%
Özsermaye Karlılık Oranı
--
5.2%
-7.43%
-7.18%
-10.12%
1.93%
EBITDA
--
43
-36
125
120
29
EBITDA Marjinali
--
2.86%
-2.04%
5.79%
5.95%
2.23%
D&A EBITDA için
--
5
5
3
3
3
Faaliyet Kârı
37
38
-41
122
117
26
Faaliyet Kâr Marjı
2.53%
2.53%
-2.32%
5.65%
5.8%
2%
Verilen Vergi Oranı
21.42%
33.33%
0%
15.12%
14.42%
21.95%
Follow-Up Questions
¿Cuáles son los estados financieros clave de Austar Lifesciences Ltd?
Según el último estado financiero (Form-10K), Austar Lifesciences Ltd tiene un total de activos de $2,083, una ganancia neta kâr de $16
¿Cuáles son los ratios financieros clave para AULSF?
El ratio corriente de Austar Lifesciences Ltd es 1.61, el margen neto es 1.06, las ventas por acción son $2.92.
¿Cómo se desglosan los ingresos de Austar Lifesciences Ltd por segmento o geografía?
Austar Lifesciences Ltd en büyük gelir kaynağı Integrated Process and Packaging Equipment & Systems olup, en son kar bildiriminde geliri 710,388,913 dir. Coğrafi olarak, China , Austar Lifesciences Ltd için ana pazar olup, geliri 1,445,798,461 dir.
¿Es rentable Austar Lifesciences Ltd?
evet, según los últimos estados financieros, Austar Lifesciences Ltd tiene una ganancia neta kâr de $16
¿Tiene Austar Lifesciences Ltd alguna deuda?
evet, Austar Lifesciences Ltd tiene una deuda de 1,292
¿Cuántas acciones en circulación tiene Austar Lifesciences Ltd?
Austar Lifesciences Ltd tiene un total de acciones en circulación de 512.58